C-terminal citrullinated peptide alters antigen-specific APC:T cell interactions leading to breach of immune tolerance.
Journal
Journal of autoimmunity
ISSN: 1095-9157
Titre abrégé: J Autoimmun
Pays: England
ID NLM: 8812164
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
07
10
2022
revised:
03
12
2022
accepted:
05
01
2023
pubmed:
28
1
2023
medline:
3
3
2023
entrez:
27
1
2023
Statut:
ppublish
Résumé
In rheumatoid arthritis, the emergence of anti-citrullinated autoimmunity is associated with HLA-antigen-T cell receptor complexes. The precise mechanisms underpinning this breach of tolerance are not well understood. Porphyromonas gingivalis expresses an enzyme capable of non-endogenous C-terminal citrullination with potential to generate citrullinated autoantigens. Here we document how C-terminal citrullination of ovalbumin peptide
Identifiants
pubmed: 36706535
pii: S0896-8411(23)00003-3
doi: 10.1016/j.jaut.2023.102994
pii:
doi:
Substances chimiques
Citrulline
29VT07BGDA
Peptides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
102994Subventions
Organisme : Versus Arthritis
ID : 20823
Pays : United Kingdom
Informations de copyright
Crown Copyright © 2023. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest IBM has received grants and honoraria from BMS, Pfizer, Lilly, Abbvie, Gilead and Galapagos.